A Phase III, Randomized, Open Label, Single Center, Study on the Effects of Treatment of Epilepsia Partialis Continua With Clobazam Compared to Treatment With or in Addition to Lorazepam and/or Clonazepam
Phase of Trial: Phase III
Latest Information Update: 16 May 2018
Price : $35 *
At a glance
- Drugs Clobazam (Primary) ; Clonazepam; Lorazepam
- Indications Epilepsy
- Focus Therapeutic Use
- 03 May 2018 Status changed from not yet recruiting to discontinued due to recruitment Issues - Lack of target population.
- 08 Jul 2014 Planned End Date changed from 1 Jul 2015 to NULL.
- 08 Jul 2014 Planned primary completion date changed to 1 Jul 2015.